Company Info
Knight Therapeutics Inc., a specialty pharmaceutical company, was established in 2014 and is publicly traded on the Toronto Stock Exchange under the ticker symbol GUD. The company is headquartered in Montreal, Quebec, Canada, and focuses on acquiring, licensing, and commercializing innovative pharmaceutical products for the Canadian and international markets. Its portfolio spans a variety of therapeutic areas, including oncology, infectious diseases, and rare or neglected conditions. Knight Therapeutics is committed to providing patients with access to high-quality medications while supporting healthcare providers with advanced treatment options. The company has built a strong reputation for its strategic partnerships and investments in the healthcare sector, positioning itself as a significant player in the pharmaceutical landscape. Its operations reflect a focus on growth and innovation, with an emphasis on serving unmet medical needs across diverse populations.